Rapid Influenza Diagnostics Market size was valued at USD 921.75 million in 2024 and is anticipated to reach USD 2.56 billion by the end of 2037, expanding at around 8.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of rapid influenza diagnostics is assessed at USD 982.22 million.
The growth of this market can be attributed to the growing prevalence of influenza all around the world. The increasing number of people globally found with weak immunity systems suffering from target ailments are expected to raise the industry growth in the forthcoming years. Human influenza viruses consisting of Type A and Type B influenza are the most significant viruses that cause disease risk in humans. These issues contribute to healthcare costs and also disrupt health-associated quality of life. As per a report by the World Health Organization, globally around 3 – 5 million people suffer from severe cases of influenza.
The increased R&D spending for the provision of technically advanced solutions to diagnose influenza is expected to lead to a higher rate of global adoption of these tests. The market revenue for these tests is expected to expand over the coming years due to the widespread use of rapid influenza diagnostic testing and a growing incidence of influenza.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.2% |
|
Base Year Market Size (2024) |
USD 921.75 million |
|
Forecast Year Market Size (2037) |
USD 2.56 billion |
|
Regional Scope |
|
End User (Hospitals, Diagnostic Centers, Research Laboratories, Office Based Settings, Nursing Home)
Based on end user, the diagnostic centers segment is anticipated to hold the largest market share of 25% by the end of 2037. The expansion can be attributed to increased demand and growing public knowledge of the advantages diagnostic centers offer in terms of giving accurate diagnoses connected to influenza respiratory infection. The importance of diagnostic facilities in identifying diseases at their earliest stages and minimizing the chance of treatment failure cannot be overstated. The patient histories and procedures of these facilities are also helping researchers enhance influenza treatment options through advanced influenza vaccine. Building diagnostic facilities that are outfitted with the highly effective necessary tests, competent specialists, and medical workers that aid in the process of recognizing influenza in a patient that is exhibiting specific symptoms or indicators is a top priority for several nations.
Test Type (Influenza A Test, Influenza B Test, Influenza A+B Test)
In terms of test type, the influenza A+B type segment in the rapid influenza diagnostics market is estimated to hold the largest revenue share during the time period between 2024 – 2036. The growth of this market can be attributed to the advantages associated with the test including ease of use, and quick diagnosis.
Our in-depth analysis of the global market includes the following segments:
|
Test Type |
|
|
End User |
|
|
Distribution Channel |
|
North American Market Forecasts
The North America rapid influenza diagnostics market is estimated to account for the highest revenue share of 33% by the end of 2037. The United States dominated the North American fast influenza diagnostic market in 2021, and it is predicted that it will continue to grow quickly throughout the foreseeable future. This can be attributed to the existence of significant market participants, a rise in the number of influenza cases, respiratory infections, etc. The CDC estimates that between October 1, 2021, and April 16, 2022, there were between 4,700,000 and 7,900,000 flu cases reported in the United States. Additionally, this flu season caused between 2,800 and 8,200 fatalities in the United States. These data demonstrate the growing need for influenza testing in the region that effectively uses quick diagnostic assays for the illness.
APAC Market Statistics
The rapid influenza diagnostics market in the Asia Pacific region is estimated to grow substantially by the end of the forecast period. The growth of this market can be ascribed to the back of growing healthcare expenditure in the region as a result of growing urbanization. Besides, increasing awareness about rapid influenza diagnostics among the people living in this world is expected to raise the market expansion of the market in the region during the forecast period.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?